A recent study suggested that combinations of metallopolymers with ineffective antibiotics exhibit synergy against MDR pathogens like E
This pattern repeats throughout treatment and is driven by fluid dynamics that scientists still do not fully understand
Well, it's a bit more nuanced than that
Class Triple agonist at GIP, GLP-1, and glucagon receptors (synthetic peptide) Origin
All three medications help lower blood sugar, but they have also gained attention for benefits that extend beyond diabetes management alone Today , healthcare providers consider how these medications affect kidney health, heart health, and long-term complications (e.g., not just the effects these meds have on your glucose levels)
doi:10.1038/s41586-026-10330-z Wharton S, et al